In last trading session, Vor Biopharma Inc (NASDAQ:VOR) saw 0.78 million shares changing hands with its beta currently measuring -0.38. Company’s recent per share price level of $0.96 trading at $0.13 or 14.85% at ring of the bell on the day assigns it a market valuation of $65.52M. That closing price of VOR’s stock is at a discount of -227.08% from its 52-week high price of $3.14 and is indicating a premium of 34.37% from its 52-week low price of $0.63. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.73 million shares which gives us an average trading volume of 945.27K if we extend that period to 3-months.
For Vor Biopharma Inc (VOR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.22. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.31 in the current quarter.
Vor Biopharma Inc (NASDAQ:VOR) trade information
Upright in the green during last session for gaining 14.85%, in the last five days VOR remained trading in the green while hitting it’s week-highest on Friday, 11/08/24 when the stock touched $0.96 price level, adding 1.46% to its value on the day. Vor Biopharma Inc’s shares saw a change of -57.42% in year-to-date performance and have moved 19.04% in past 5-day. Vor Biopharma Inc (NASDAQ:VOR) showed a performance of 46.33% in past 30-days. Number of shares sold short was 1.71 million shares which calculate 2.99 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 6 to the stock, which implies a rise of 84.0% to its current value. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -525.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -525.0% for stock’s current value.
Vor Biopharma Inc (VOR) estimates and forecasts
Statistics highlight that Vor Biopharma Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -43.98% of value to its shares in past 6 months, showing an annual growth rate of 13.71% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -73.43% during past 5 years.
Vor Biopharma Inc (NASDAQ:VOR)’s Major holders
Insiders are in possession of 1.17% of company’s total shares while institution are holding 81.25 percent of that, with stock having share float percentage of 82.21%. Investors also watch the number of corporate investors in a company very closely, which is 81.25% institutions for Vor Biopharma Inc that are currently holding shares of the company. RA CAPITAL MANAGEMENT, L.P. is the top institutional holder at VOR for having 22.75 million shares of worth $22.75 million. And as of 2024-06-30, it was holding 33.439 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 7.08 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.4009 of outstanding shares, having a total worth of $7.08 million.
